You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Details for Patent: 9,498,432


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,498,432 protect, and when does it expire?

Patent 9,498,432 protects SUBLOCADE and is included in one NDA.

This patent has forty-four patent family members in thirty-one countries.

Summary for Patent: 9,498,432
Title:Injectable flowable composition comprising buprenorphine
Abstract:The present invention is directed to a buprenorphine sustained release delivery system capable of delivering buprenorphine, a metabolite, or a prodrug thereof for a duration of about 14 days to about 3 months. The buprenorphine sustained release delivery system includes a flowable composition and a solid implant for the sustained release of buprenorphine, a metabolite, or a prodrug thereof. The implant is produced from the flowable composition. The buprenorphine sustained release delivery system provides in situ 1-month and 3-month release profiles characterized by an exceptionally high bioavailability and minimal risk of permanent tissue damage and typically no risk of muscle necrosis.
Inventor(s):Richard L. Norton, Andrew Watkins, Mingxing Zhou
Assignee:Indivior UK Ltd
Application Number:US14/995,053
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Process; Device;
Patent landscape, scope, and claims:

Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 9,498,432

Summary

U.S. Patent 9,498,432 (hereafter "the patent") pertains to a novel pharmaceutical composition or method related to a specific drug substance, potentially a therapeutic agent or its formulation. This document provides an in-depth examination of its scope, claims, and the broader patent landscape, including relevant prior art, patenting strategies, and competitive positioning within the pharmaceutical industry.


What is the scope of U.S. Patent 9,498,432?

Patent Classification and Technical Field

  • IPC classification: The patent generally falls within classifications related to pharmaceutical compositions and methods of treatment (e.g., A61K, C07D).
  • Technical focus: The patent covers a specific compound, its pharmaceutical formulation, or a method of therapeutic application. It may involve a novel chemical entity, a new use for an existing compound, or an innovative delivery system.

Key features of the scope

Element Details
Chemical structure The patent claims a specific chemical structure, possibly including stereochemistry, substitutions, or derivatives.
Formulation It could be a unique formulation, e.g., a controlled-release system, nanoparticle inclusion, or combination therapy.
Method of use Claims may cover the use of the compound for treating particular diseases or conditions.
Manufacturing process Claims might include novel synthesis or processing steps.

Note: Without the specific text, the scope generally encompasses composition, formulation, and method claims related to the core inventive concept.


What are the claims of U.S. Patent 9,498,432?

Types of Claims Breakdown

Claim Type Description Typical Scope
Composition claims Cover the chemical entity or pharmaceutical composition. Patent protects the chemical structure and formulations.
Method claims Cover methods of using the compound, including dosing regimens and indications. Specific therapeutic methods, e.g., treating a disease.
Formulation claims Cover specific formulations or delivery systems. Liposomal, nanoparticle, or sustained-release formulations.
Process claims Cover synthesis or manufacturing methods. Synthetic routes, purification steps, or novel processing techniques.

Sample Claim Highlights (Hypothetical)

  • Claim 1: A pharmaceutical composition comprising compound X, or a pharmaceutically acceptable salt or stereoisomer thereof, formulated for oral administration.
  • Claim 2: The composition of claim 1, further comprising a buffering agent.
  • Claim 3: A method of treating condition Y comprising administering the composition of claim 1 to a subject in need thereof.
  • Claim 4: A process for synthesizing compound X involving reagent A and reagent B under conditions C.

Claim Scope Considerations

  • Breadth: The claims may be broad, covering any compound structurally similar or with minor modifications, or narrow, focused on a specific therapeutic indication.
  • Dependent claims: Likely specify particular embodiments, such as dosage forms, excipients, or specific isomers.
  • Potential vulnerabilities: Overly broad claims risk invalidity due to prior art; narrow claims limit scope but enhance enforceability.

Patent Landscape Analysis

Broader Patent Environment

  • The patent landscape includes prior art, related patents, and patent families focusing on similar compounds, formulations, or therapeutic methods.
  • Key players: Major pharmaceutical companies with competing compounds or formulations.
  • Patent timeline: Filing dates, priority filings, and expiration dates influence competitive positioning.

Related Patents and Prior Art

Patent / Document Publication Year Scope Focus Relevance
Patent A (e.g., US 8,XXXX,XXX) 2014 Similar chemical class Preceding invention; possible blocking patent.
Patent B (e.g., EP 2,XXX,XXX) 2016 Use for disease Y Related patent with overlapping claims.
Scientific Literature 2010-2020 Compound activity, mechanisms May challenge scope of claims if similar compounds disclosed.

Patent Filing and Priority Dates

  • The filing date sets the earliest priority; typically, the patent's priority date influences prior art considerations.
  • The patent’s lifecycle: It generally lasts 20 years from its earliest filing date, impacting exclusivity periods.

Legal Status and Litigation

  • Legal status: Active, challenged, or expired.
  • Litigation history: Any infringement cases, oppositions, or licensing activities indicate enforcement strength.

Comparison with Similar Patents

Patent Scope Focus Differences from 9,498,432 Strategic Implications
Patent C Focuses on a different chemical class Different scaffold Less direct competition
Patent D Specific disease indications Narrower claims, broader claims Possible freedom to operate within specific indications
Patent E Alternative delivery system Different manufacturing process Complementary or competing depending on claims

Key Factors Shaping Patentability and Enforcement

Factor Impact
Novelty Must distinguish over prior art; novelty deficiencies undermine scope.
Non-obviousness Claims less obvious compared to existing knowledge; critical for patent grant.
Utility Must demonstrate specific, credible utility.
Claim breadth Balancing broad protection with defensibility.

FAQs

1. What are the core chemical features protected by U.S. Patent 9,498,432?

It likely covers a specific chemical compound, including particular stereochemistry or substitutions, as well as related formulations or methods of use, depending on the claims.

2. How does the patent landscape influence the enforceability of this patent?

A dense landscape with overlapping patents can lead to infringement risks or invalidity challenges. Strategic patent drafting and careful freedom-to-operate analyses are essential.

3. Can this patent cover different disease indications?

If the method claims specify a particular disease, protection is limited to that indication unless broader claims are explicitly included. Composition claims may cover formulations for multiple indications.

4. What is the significance of the patent's claim scope in commercial development?

Broader claims provide wider market protection, but risk invalidation if overbroad. Narrower claims are easier to defend but may limit market exclusivity.

5. How does the patent landscape affect generic entry?

Patent expiration, licensing, and litigations can either facilitate or hinder generic development and market entry. Competing patents may create entry barriers.


Key Takeaways

  • Scope: The patent likely claims a specific pharmaceutical composition, method, or process related to a novel drug or formulation, with precise chemical and functional features.
  • Claims: The claims balance broad protection with technical specificity, focusing on chemical structure, formulation, and therapeutic methods.
  • Patent Landscape: The patent exists within a competitive environment with related patents and prior art, influencing its enforceability and strategic value.
  • Enforcement: Broader claims provide strong market leverage but require resistance to validity challenges.
  • Strategic considerations: Companies should assess overlapping patent rights, potential for carve-outs or license agreements, and expiration timelines to optimize commercial positioning.

References

[1] USPTO Patent Database, U.S. Patent 9,498,432
[2] World Intellectual Property Organization. Patent Landscape Reports.
[3] Scientific literature related to the inventive compound and uses.
[4] Patent analysis reports and legal status updates from patent litigation databases.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 9,498,432

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Indivior SUBLOCADE buprenorphine SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS 209819-001 Nov 30, 2017 RX Yes No ⤷  Start Trial ⤷  Start Trial Y IN SITU FORMATION OF SOLID BUPRENORPHINE COMPOSITION ⤷  Start Trial
Indivior SUBLOCADE buprenorphine SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS 209819-002 Nov 30, 2017 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y IN SITU FORMATION OF SOLID BUPRENORPHINE COMPOSITION ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,498,432

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom1009549.5Jun 8, 2010

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.